Citius Pharmaceuticals, Inc.
CTXR
$0.968
-$0.021-2.12%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -39.68M | -39.14M | -38.29M | -36.20M | -38.18M |
| Total Depreciation and Amortization | 213.40K | 209.60K | 205.90K | 202.10K | 198.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.41M | 12.41M | 13.13M | 11.14M | 9.23M |
| Change in Net Operating Assets | 1.26M | -1.69M | -4.14M | -5.44M | -1.62M |
| Cash from Operations | -26.79M | -28.20M | -29.09M | -30.30M | -30.37M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -5.00M | -5.00M | -- | -- | -- |
| Cash from Investing | -5.00M | -5.00M | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 16.38M | 13.80M | 14.92M | 15.00M | 15.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -3.83M | -3.83M | -1.20M | -1.20M | -1.20M |
| Cash from Financing | 12.55M | 9.97M | 13.72M | 13.80M | 13.83M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -19.25M | -23.23M | -15.37M | -16.51M | -16.54M |